Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biogen Pharmachem Industries Ltd has informed the BSE that its trading window for dealing in company securities will remain closed from Wednesday, 1st April 2026 until 48 hours after the announcement of audited financial results for the quarter and year ended 31st March 2026. This closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's own insider trading code. The date of the board meeting to approve the audited results will be communicated later. The intimation was signed by Director Kelash Bunkar on 17th March 2026.
This is a routine compliance filing ahead of the FY26 audited results. No insider trading activity or change in shareholding is involved. Shareholders should expect the FY26 audited results announcement in the coming weeks, during which trading by insiders will be restricted.